Trialect

Active

Career Development Grant-PERF®-CNS Shields Research Grant.

Pediatric Epilepsy Research Foundation®

This research grant supports translational or clinical research by a child neurologist or developmental pediatrician early in his/her academic career. The selected investigator will receive a $150,000 grant of $75,000 per year for two years.

Specialties

Clinical Trials

Neurosurgery

Neurosciences

Pediatrics

Eligibility Requirements

The applicant completed training in child neurology or neurodevelopmental disabilities in an accredited program no more than ten (10) years prior to application.
The PERF®-CNS Shields Research Grant must have a clinical research/patient care component. Research does not need to focus on epilepsy.
There are no citizenship requirements however the research must be conducted in the United States or Canada.
The applicant is a Junior or Active member of the Child Neurology Society.
Currently funded research is disqualified except for an NIH Kl2, K12, T32, or R25 grant.

Sponsor Details

Sponsor Institute/Organizations: Pediatric Epilepsy Research Foundation®

Address: Pediatric Epilepsy Research Foundation® 8390 Lyndon B. Johnson Fwy, Suite 350 Dallas, TX 75243-1188

View Funding Opportunity

Grant

Letter Of Intent Deadline:

Apr 11, 2025

Final Deadline:

Apr 11, 2025

Funding Amount:

$150,000

Questions and Answers

Commonly asked questions about this funding opportunity from the host and other attendees.

Which Grant should I apply for?

The Pediatric Epilepsy Research Foundation® (PERF®)- CNS Elterman Research Grant supports clinical or basic science research while the PERF®- CNS Shields Research Grant supports translational or clinical research. The applicant should review the “Career Development Grants Overview and Guidance” for eligibility criteria and application instructions.

Is there a difference in the relevant scientific agenda for the PERF®-CNS Elterman vs the PERF®-CNS Shields award?

No. However, the Shields grant needs to have a clinical component, whereas the Elterman grant does not. The PERF®-CNS grants do not need to be related to epilepsy. Currently funded research is disqualified for the PERF Elterman and Shields Grants except for an NIH KL2, K12, R25 or T32 grant. Candidates are eligible for the PERF Elterman and Shields Grants if they have received an NIH KL2, K12, R25 or T32 grant.

Am I eligible to apply if I have a mentored NIH grant?

No, you are not eligible to apply if you have a NIH K08, K23, or K99.

Can CNS members who previously received a CNS or CNF grant or award apply for a PERF®-CNS Elterman/Shields research grant?

Yes, the Awards Committee will consider every application. However, when considering two or more outstanding proposals, the Committee may give preference to the applicant without prior funding from CNS, CNF, or PERF.

When does the funding cycle begin?

Award recipients will be notified by the end of June of the granting year. The funding cycle begins September 1 contingent on execution of the grant agreement and IRB approval of the research project.

CNS Annual Meeting Abstract Requirement.

During the grant period, or in the following year (i.e. April), the Awardee will be required to submit an abstract for presentation to the CNS Annual Meeting. Should the abstract be accepted for publication, the Awardee will receive a fee waiver to cover the cost of meeting registration. We also anticipate that projects funded by this grant will lead to publication of original research in peer-reviewed journals. The abstract for the poster/platform should be appropriately modified to conform with the CNS Meeting Guidelines (Objective, Methods, Results, Conclusions).